Advertisement
Disease-modifying antirheumatic drug therapy for rheumatoid arthritis treatment also cuts cardiovascular disease risk

Early Therapy for Rheumatoid Arthritis May Slow Heart Disease

0
RA treatment response does not appear to impact improvement in vascular stiffness
The COVID-19 pandemic threatens decades of progress in reducing preventable deaths in children worldwide

Pandemic Threatens Gains in Reducing Preventable Childhood Deaths

0
Many countries experiencing disruptions in childhood checkups, vaccinations, malnutrition programs
A new portable COVID-19 test that can provide results within 15 minutes and process up to 30 samples an hour could be available by the end of the year

New COVID-19 Test Provides Results in 15 Minutes

0
Test correctly diagnoses infection 90 percent of the time and a negative result 100 percent of the time
A "potentially unexplained" illness in a participant has led AstraZeneca to halt a late-stage clinical trial of its COVID-19 vaccine.

Clinical Trial of AstraZeneca COVID-19 Vaccine Paused After Illness

0
Company investigating whether the illness may be a side effect of the vaccine
More than 500

More Than Half a Million U.S. Children Already Infected With COVID-19

0
There were 70,630 new child cases reported between Aug. 20 and Sept. 3
Children with lower birth size and slower body mass index gain in early childhood have lower lung function at 7 years

Weight Gain Pattern Early in Life May Affect Later Lung Function

0
Children with early accelerated BMI gain have higher lung function at age 7 years
Current low-intensity smokers have an increased risk for respiratory and lung cancer mortality

Respiratory, Lung Cancer Death Up Even With Low-Intensity Smoking

0
Risks for respiratory and lung cancer mortality increased for those smoking <10 cigarettes per day
The highest ethical and scientific standards will be followed in testing and manufacturing vaccines against the new coronavirus

Drug Companies Say Ethical, Scientific Standards Will Be Followed in Making COVID-19 Vaccines

0
The pledge issued Tuesday is meant to increase public confidence in any approved vaccines
The median time from COVID-19 symptom onset to viral clearance is 36 days

Median of 36 Days Found From COVID-19 Symptom Onset to Viral Clearance

0
Slight increase in time from symptom onset to viral clearance seen with increasing age, disease severity
Among children with COVID-19 or seasonal influenza

Child Hospital, ICU Admission Rates Similar for COVID-19, Flu

0
But more clinical symptoms reported at the time of diagnosis for children with COVID-19 versus flu